Cargando…
Identification of genomic features associated with immunotherapy response in gastrointestinal cancers
Gastrointestinal (GI) cancers prevail and account for an extremely high number of cancer deaths worldwide. The traditional treatment strategies, including surgery, chemotherapy, radiotherapy, and targeted therapy, have a limited therapeutic effect for advanced GI cancers. Recently, immunotherapy has...
Autores principales: | He, Yin, Liu, Zhi-Xian, Jiang, Ze-Hang, Wang, Xiao-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475671/ https://www.ncbi.nlm.nih.gov/pubmed/31040893 http://dx.doi.org/10.4251/wjgo.v11.i4.270 |
Ejemplares similares
-
Immunotherapy in Gastrointestinal Cancers
por: Procaccio, Letizia, et al.
Publicado: (2017) -
Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?
por: Yan, Cong, et al.
Publicado: (2019) -
Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
por: Lu, Zhihao, et al.
Publicado: (2020) -
Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers
por: Li, Bo, et al.
Publicado: (2023) -
A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer
por: Jiao, Xi, et al.
Publicado: (2021)